CDC DFWED NARST Sensititre Supplies
ID: CDC-DFWED-NARST-Sensititre-SuppliesType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Other Professional Equipment and Supplies Merchant Wholesalers (423490)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/e91ef30f10024c8ba17fcbd38b10ff8c/view
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.

    Point(s) of Contact
    Ashley Williams
    dal3@cdc.gov
    Sheena Delaine
    kpz5@cdc.gov
    Files
    Title
    Posted
    A11- Notice of Intent to Sole Source.pdf
    The CDC plans to award a sole source contract to ThermoFisher Scientific for antimicrobial resistance surveillance supplies, specifically utilizing Sensititre™ broth microdilution testing. This testing method is proprietary and has been integral to consistency in monitoring since 1996 under the National Antimicrobial Resistance Monitoring System, a collaborative effort among the CDC, FDA, and USDA. The unique nature of these supplies necessitates this single-source approach, as other testing methods would require extensive validation and could disrupt timely surveillance and analysis, critical for comparing human and retail data. Although this notice does not serve as a call for competitive bids, interested parties may respond within 15 days. Proposals should be directed to contract specialist Ashley Williams. The government retains discretion over the decision to pursue competitive procurement based on received expressions of interest.
    A13- Sole Source Justification_V2_ SL signed 6 Nov 24_Redacted.pdf
    This document justifies the sole source procurement for antimicrobial resistance testing supplies necessary for the Centers for Disease Control and Prevention (CDC) under the National Antimicrobial Resistance Monitoring System (NARMS). The proposed vendor is ThermoFisher Scientific, whose proprietary Sensititre™ broth microdilution testing products are essential for maintaining a standardized approach to monitoring enteric bacteria resistance, a method in use since 1996. The justification outlines that only specific proprietary materials from Remel, Inc. are compatible with existing testing equipment, making it impractical and costly to consider alternatives. Switching to another manufacturer would necessitate substantial investments in new equipment and validation processes, disrupting the continuity and comparative capability required for effective surveillance and data analysis. The document concludes with certifications from the Program Official and Contracting Officer affirming the necessity and accuracy of the sole source claim, citing that no other suppliers meet the unique needs of this surveillance initiative. Overall, the justification reflects compliance with federal acquisition regulations permitting limited source procurement under specific circumstances.
    Lifecycle
    Title
    Type
    CDC DFWED NARST Sensititre Supplies
    Currently viewing
    Sources Sought
    Similar Opportunities
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves a range of tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA) or 510(k) approval, and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Proposals are due by December 2, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. Interested parties can contact Shayna Connery at xvj9@cdc.gov or (404) 498-0715 for further information.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    RISER Meet and Greet
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified large businesses under NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, to participate in the RISER Meet and Greet initiative aimed at enhancing public health surveillance and laboratory capacity. This opportunity is part of a phased approach to identify capable businesses that can provide diagnostic and testing services, ultimately expanding the CDC's inventory of reference pathogens and detection kits for rapid response during public health emergencies. Interested parties must respond by November 14, 2024, with their capabilities and relevant past performance, as the virtual meet-and-greet conference is scheduled for December 11, 2024. For further inquiries, interested businesses can contact Jennifer Gartzke at jgartzke@cdc.gov or call 404-498-0020.
    6550--NEW - Covid Testing - Base + 2
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Cepheid for the provision of 510K/FDA approved COVID-19 testing supplies, specifically the Cepheid Xpress COV-2/Flu/RSV Plus and Xpress COVID Plus tests. This procurement involves a Firm-Fixed price, Indefinite Delivery Indefinite Quantity (IDIQ) contract that includes a base year and two additional ordering periods, with the vendor required to provide educational materials and ensure compliance with health regulations while communicating any supply shortages. The exclusive procurement from Cepheid is justified by their unique capability to meet the VA's requirements efficiently, emphasizing the importance of timely COVID-19 testing solutions for veterans and healthcare staff. Interested parties may submit capability statements or proposals for consideration, but if no responses are received within seven days, the contract will be awarded to Cepheid. For further inquiries, contact Susan Flores at Susan.flores2@va.gov or (210) 694-6227.
    Notice of Intent to Award Sole Source
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source contract to Metro Health for access to the Epic Cosmos electronic health record dataset. This dataset, which encompasses electronic health records from over 240 million patients across all 50 states, is crucial for assessing real-world effectiveness questions, particularly regarding rare health outcomes, due to its real-time updates and comprehensive features. Interested parties may express their interest and capability to respond to this requirement within fifteen days of this notice, with all communications directed to contract specialist Peter Loree at zus0@cdc.gov. This procurement is not open for competitive quotations, and the government retains discretion over whether to pursue competitive procurement based on the responses received.
    6640--FY 25 Molecular Random Access Analyzer Notification of Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VA Caribbean Healthcare System through Network Contracting Office 8, intends to negotiate a sole source contract with Cepheid for the provision of Molecular Random Access Analyzers. This procurement is essential for meeting the government's requirement for rapid, simultaneous testing, delivering results in under three hours, which is critical for healthcare support to veterans. The contract will cover a base year of twelve months, with four optional extensions of twelve months each, and is being pursued under FAR part 8.405-6 (1)(B) due to Cepheid's exclusivity as the sole provider in Puerto Rico. Interested parties must submit any responses challenging the sole source by November 14, 2024, at 1:30 PM EST, to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov.
    Serological Assays for the detection and characterization of influenza viruses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the provision of serological assays aimed at detecting and characterizing influenza viruses. This contract encompasses a 12-month base period with four additional 12-month option periods, focusing on testing immunological responses from human samples collected during vaccine effectiveness studies, randomized controlled trials, and outbreak investigations using Hemagglutination Inhibition (HAI) assays. The services are critical for understanding vaccine efficacy and managing influenza outbreaks, with the government supplying necessary standard operating procedures, proficiency panels, and controls to ensure proper assay performance. Interested parties should contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further details, as this opportunity is set aside for small businesses under the SBA guidelines.
    BIOFIRE Defense, LLC Test Kits and Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a fixed-price contract to BioFire Defense, LLC for the provision of BIOFIRE® Reagent Kits and associated test kits. The procurement aims to secure proprietary test kits and reagents essential for the NIH Clinical Center's Department of Laboratory Medicine, which supports patient care and research by detecting pathogens in various patient specimens, including blood and respiratory samples. The BioFire test kits are critical for rapid diagnostics, allowing clinicians to initiate timely treatment for infections, and BioFire Defense, LLC is the sole source for these products due to compatibility requirements with government-owned analyzers. Interested parties capable of providing similar products may submit capability statements by November 17, 2024, at 12:00 PM EST to Sheri Eiri at sheri.eiri@nih.gov.
    Qiagen LLC QIAsymphony DSP DNA Midi Kits, filter tips and supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to Qiagen LLC for QIAsymphony DSP DNA Midi Kits, filter tips, and related supplies, essential for the Microbiology Service section of the Department of Laboratory Medicine. This procurement aims to acquire reagents and supplies necessary for the efficient extraction of nucleic acids from clinical samples, which is critical for timely detection of infectious agents and supporting ongoing clinical testing. The items will be utilized with existing QIAsymphony SP and QIAgility instruments, which are vital for the laboratory's operations and the development of novel tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 2:30 PM EST, as this is not a request for proposals.
    Thermo Fisher Scientific Sorvall Legend Centrifuges Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Thermo Fisher Scientific for preventative maintenance services on thirty-one Sorvall Legend Centrifuges. The primary objective of this procurement is to ensure the continued operational integrity of critical laboratory equipment used in the manufacturing of cell-based therapies for patients enrolled in clinical trials, adhering to stringent FDA regulations. Given the importance of these centrifuges in supporting patient care and the potential risks associated with transitioning to a new vendor, the NIH emphasizes that only the original equipment manufacturer can perform necessary software updates and maintenance. Interested parties capable of providing similar services must submit a capability statement by November 17, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.